Nuevolution AB (publ) announced the appointment of Mr. Johnny Stilou as Chief Financial Officer (CFO) with immediate effect. Johnny Stilou will take over the position as CFO after Mr. Henrik Simonsen, who will be leaving Nuevolution to pursue other opportunities. Johnny Stilou, joined Nuevolution in February 2018 in the position as Director of Investor Relations & Corporate Communication. Most recently he was CFO at Fritz Schur Technical Group, and prior to this during the eight years from 2008 to 2016, he was CFO at the Nasdaq Copenhagen public listed Veloxis Pharmaceuticals (midcap). Johnny Stilou will remain responsible for Nuevolution's investor relations and corporate communication. With the organizational change, the company will consider the opportunity to strengthen these areas further.